Yirendai Ltd. (NYSE:YRD) enjoyed a 74.75% run-up in share price since hitting record low of $18.3. The stock managed 3.53% rise and now stands at $31.98 as of July 17, 2017. At recent session, the prices were hovering between $30.5 and $32.9. This company shares are -4.32% up from its target price of $30.6 and the current market capitalization stands at $1.77B. The recent change has given its price a 29.21% lead over SMA 50 and -24.47% deficit over its 52-week high. The stock witnessed 33.7% gains, 33.7% gains and 45.76% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found YRD’s volatility during a week at 7.04% and during a month it has been found around 4.09%.

Yirendai Ltd. (YRD) Top Holders

Institutional investors currently hold around $143 million or 7.7% in YRD stock. Look at its top three institutional owners. Acadian Asset Management Llc owns $30.05 million in Yirendai Ltd., which represents roughly 1.7% of the company’s market cap and approximately 21.01% of the institutional ownership. Similar statistics are true for the second largest owner, Numeric Investors Llc, which owns 947,251 shares of the stock are valued at $29.26 million. The third largest holder is Emerald Acquisition Ltd., which currently holds $13.28 million worth of this stock and that ownership represents nearly 0.75% of its market capitalization.

Yirendai Ltd. 13F Filings

At the end of Mar reporting period, 35 institutional holders increased their position in Yirendai Ltd. (NYSE:YRD) by some 1,343,454 shares, 22 decreased positions by 2,144,331 and 5 held positions by 1,150,551. That puts total institutional holdings at 4,638,336 shares, according to SEC filings. The stock grabbed 21 new institutional investments totaling 973,854 shares while 12 institutional investors sold out their entire positions totaling 1,445,115 shares.

Yirendai Ltd. (YRD) Analyst Guide

Several analysts have released their opinion on Yirendai Ltd. (NYSE:YRD), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 1 strong sell ratings, collectively assigning a 2.67 average brokerage recommendation.

SHARE
Previous articleAnalyst Views On Top Movers In Recent Trade: JPMorgan Chase & Co. (JPM), Alnylam Pharmaceuticals, Inc. (ALNY)
Next article43 hedge funds sold their entire positions in Aimmune Therapeutics, Inc. (AIMT)